Anthrax

• FDA approval · 2022-12-07
  FDA Approved: DOXYCYCLINE — Original Application (Par Health USA, LLC)

  FDA approved a generic doxycycline product under an original new drug application by Par Health USA, LLC (ANDA216690).

• FDA approval · 2021-06-02
  FDA Approved: RAXIBACUMAB — Supplemental Application (Emergent Manufacturing Operations Baltimore LLC)

  FDA approved a supplemental application for manufacturing operations of RAXIBACUMAB (raxibacumab) by Emergent Manufacturing Operations Balti…

• FDA approval · 2019-11-29
  FDA Approved: ANTHIM — Supplemental Application (Elusys Therapeutics, Inc.)

  FDA approved a supplemental application for ANTHIM (obiltoxaximab) from Elusys Therapeutics, Inc.